$2.23
-0.124[-5.27%]
Last update: 7:17PM Get Real Time Here
CASI Pharmaceuticals
(NASDAQ:CASI)Latest News for CASI Pharmaceuticals Stock (NASDAQ:CASI)
CASI Pharmaceuticals Stock (NASDAQ: CASI)
Categories: All
Monday, April 08, 2024
- CASI Pharmaceuticals Discloses Material Development Relating To Its Dispute With JuventasBenzinga Newsdesk - Apr 8, 2024, 5:03PM
- CASI Pharmaceuticals Wins Emergency Relief Regarding the Dispute with Juventas Cell Therapy Ltd Prohibiting Juventas from Commercializing CNCT19Benzinga Newsdesk - Apr 8, 2024, 7:34AM
Thursday, March 28, 2024
- CASI Pharmaceuticals Q4 EPS $(0.45) Misses $(0.24) Estimate, Sales $6.87M Miss $9.41M EstimateBenzinga Newsdesk - Mar 28, 2024, 8:45AM
- Recap: CASI Pharmaceuticals Q4 EarningsBenzinga Insights - Mar 28, 2024, 8:20AM
- CASI Pharmaceuticals FY2023 GAAP EPS $(2.02) Misses $(1.93) Estimate, Sales $33.88M Miss $36.42M EstimateBenzinga Newsdesk - Mar 28, 2024, 7:29AM
Friday, March 08, 2024
Thursday, March 07, 2024
Tuesday, March 05, 2024
- CASI Pharmaceuticals Blood Cancer Drug Shows Encouraging Clinical Efficacy In Chinese PatientsVandana Singh - Mar 5, 2024, 12:16PM
- CASI Pharmaceuticals Shares Halted On Circuit Breaker To The Downside, Stock Now Up 13.1%Benzinga Newsdesk - Mar 5, 2024, 9:41AM
- 12 Health Care Stocks Moving In Tuesday's Pre-Market SessionBenzinga Insights - Mar 5, 2024, 8:09AM
- CASI Pharmaceuticals shares are trading higher after the company reported interim Phase 1 data for BI-1206 for the treatment of relapsed/refractory indolent Non-Hodgkin's Lymphoma in China.Benzinga Newsdesk - Mar 5, 2024, 7:44AM
- CASI Pharmaceuticals Report Interim Phase 1 Data For BI-1206 In The Treatment Of Relapsed/Refractory Indolent Non-Hodgkin's Lymphoma In ChinaBenzinga Newsdesk - Mar 5, 2024, 7:04AM
Friday, February 16, 2024
Thursday, January 25, 2024
Wednesday, November 15, 2023
Friday, November 03, 2023
Wednesday, October 11, 2023
Wednesday, September 27, 2023
Monday, August 14, 2023
Friday, August 11, 2023
Monday, May 22, 2023
Wednesday, May 17, 2023
Monday, May 01, 2023
Monday, April 10, 2023
Tuesday, January 31, 2023
Friday, January 06, 2023
Monday, December 26, 2022
Thursday, December 15, 2022
Wednesday, November 16, 2022
Tuesday, November 15, 2022
Monday, November 14, 2022
Monday, September 26, 2022
Friday, September 23, 2022
Friday, September 09, 2022
Wednesday, September 07, 2022
Monday, August 29, 2022
Tuesday, August 23, 2022
Wednesday, August 17, 2022
Tuesday, August 16, 2022
Monday, August 15, 2022
Friday, August 12, 2022
- CASI Pharmaceuticals shares are trading lower after the company reported Q2 earnings results.Michael Horton - Aug 12, 2022, 11:42AM
- Recap: CASI Pharmaceuticals Q2 EarningsBenzinga Insights - Aug 12, 2022, 7:21AM
- CASI Pharmaceuticals Q2 EPS $(0.56) Beats $(0.64) Estimate, Sales $8.57M Beat $7.87M EstimateBill Haddad - Aug 12, 2022, 7:14AM
- Earnings Scheduled For August 12, 2022Benzinga Insights - Aug 12, 2022, 4:42AM